Justus-Liebig University

Giessen 35392

0 studies enrolling now · 2 studies all time

What they study most

Chronic Lymphocytic Leukemia, Lymphoma, Non Hodgkin Lymphoma

Studies at this site

• A Study Evaluating Safety, PK, and Efficacy of Tafasitamab and Parsaclisib in Participants With Relapsed/Refractory Non Hodgkin Lymphoma (R/R NHL) or Chronic Lymphocytic Leukemia (CLL) — Stopped early
• A Study of INCB050465 in Relapsed or Refractory Mantle Cell Lymphoma Previously Treated With or Without a Bruton's Tyrosine Kinase (BTK) Inhibitor — Completed